UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).
Bird
Jenny
J
Avon Haematology Unit, Bristol Haematology and Oncology Centre, Bristol, UK. bcsh@b-s-h.org.uk
Behrens
Judith
J
Westin
Jan
J
Turesson
Ingemar
I
Drayson
Mark
M
Beetham
Robert
R
D'Sa
Shirley
S
Soutar
Richard
R
Waage
Anders
A
Gulbrandsen
Nina
N
Gregersen
Henrik
H
Low
Eric
E
D000465:Algorithms; D015415:Biomarkers / Q000097:blood; D002471:Cell Transformation, Neoplastic; D003937:Diagnosis, Differential; D018450:Disease Progression; D006801:Humans; D007136:Immunoglobulins / Q000097:blood*; D008134:Long-Term Care / Q000379:methods; D008232:Lymphoproliferative Disorders / Q000175:diagnosis; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000175:diagnosis* / Q000453:epidemiology; D009101:Multiple Myeloma / Q000175:diagnosis; D011379:Prognosis; D008258:Waldenstrom Macroglobulinemia / Q000175:diagnosis
D015415:Biomarkers; D007136:Immunoglobulins; C009823:M-proteins (Myeloma)